BackgroundCheck.run
Search For

Jeffrey D Mcmahon, 554611 Opal Rdg Ln, Arlington, TX 76005

Known as:
Jeffrey David Mcmahon Jeff D Mcmahon Jeffd Mcmahon Jeff Mc Jeff Mc Matton
Related to:
Beverly J Mcmahon 82

Jeffrey Mcmahon Phones & Addresses

Arlington, TX   

400 Bourland Rd APT 623, Keller, TX 76248   

Walnut Creek, CA   

San Francisco, CA   

2606 Humboldt Ave, Minneapolis, MN 55408    952-3745864   

Work

Company: Citigroup - Washington, DC Apr 2014 Position: Personal banker/loan officer

Education

School / High School: Kaplan- Saint Paul, MN 2013 Specialities: Real Estate
Get Report
Control this profile

Mentions for Jeffrey D Mcmahon

Career records & work history

Medicine Doctors

Jeffrey R. Mcmahon

Specialties:
Internal Medicine, Urgent Care Medicine
Work:
Family Doctors Urgent Care Clinic
2600 Belle Chasse Hwy STE B, Gretna, LA 70056
504-3492273 (phone) 504-3496160 (fax)
Languages:
English
Description:
Mr. McMahon works in Gretna, LA and specializes in Internal Medicine and Urgent Care Medicine. Mr. McMahon is affiliated with West Jefferson Medical Center.

Jeffrey Mcmahon resumes & CV records

Resumes

Jeffrey Mcmahon Photo 37

Student At University Of Michigan

Position:
Drum Major at University of Michigan Marching Band
Location:
Ann Arbor, Michigan
Industry:
Civil Engineering
Work:
University of Michigan Marching Band since Apr 2011
Drum Major New Life Church Jun 2012 - Aug 2012
Intern Lowe’s Companies May 2010 - Aug 2010
Sales Associate
Education:
University of Michigan 2008 - 2012
Bachelor of Science in Engineering, Civil& Environmental Engineering
Jeffrey Mcmahon Photo 38

Jeffrey Mcmahon - Washington, DC

Work:
Citigroup - Washington, DC Apr 2014 to Dec 2014
Personal Banker/Loan Officer Wells Fargo Bank, NA - Minneapolis, MN Mar 2013 to Aug 2013
Personal Banker YMCA - Saint Paul, MN Sep 2011 to Mar 2013
Advisor GreatWaters Brewery - Saint Paul, MN Aug 2009 to Oct 2011
Server/Bartender Nordstrom Mall of America - Bloomington, MN Sep 2008 to Mar 2009
Sales Representative E-Cap Electronic Banking - Saint Paul, MN Jan 2008 to Aug 2008
Account Executive AON Corporation - Chicago, IL Dec 2006 to Jan 2008
Account Executive Mass Mutual - Minneapolis, MN Mar 2006 to Nov 2006
Financial Advisor U.S. Bancorp - Saint Paul, MN May 2002 to Nov 2005
Personal Banker
Education:
Kaplan - Saint Paul, MN 2013 to 2013
Real Estate Dearborn Financial - Bloomington, MN 2006 to 2010
Finance Saint Paul College - Saint Paul, MN 2006 to 2008
General Pro Source - Minneapolis, MN 2003 to 2005
Investments AIB/American Institute of Banking - Minneapolis, MN 1990 to 1995
Banking/Finance

Publications & IP owners

Us Patents

Modulators Of Cxcr7

US Patent:
8288373, Oct 16, 2012
Filed:
Nov 4, 2009
Appl. No.:
12/612638
Inventors:
Xi Chen - Palo Alto CA, US
Pingchen Fan - Fremont CA, US
Mark M. Gleason - Redwood City CA, US
Juan C. Jaen - Burlingame CA, US
Lianfa Li - Palo Alto CA, US
Jeffrey P. McMahon - Mountain View CA, US
Jay Powers - Pacifica CA, US
Yibin Zeng - Foster City CA, US
Penglie Zhang - Foster City CA, US
Assignee:
Chemocentryx, Inc. - Mountain View CA
International Classification:
A61K 31/497
C07D 403/00
US Classification:
514218, 540575
Abstract:
Compounds having formula I,.

Modulators Of Cxcr7

US Patent:
2010031, Dec 9, 2010
Filed:
May 12, 2010
Appl. No.:
12/778913
Inventors:
Xi CHEN - Palo Alto CA, US
Dean R. DRAGOLI - Los Altos CA, US
Pingchen FAN - Fremont CA, US
Mark M. GLEASON - Redwood City CA, US
Juan C. JAEN - Burlingame CA, US
Lianfa LI - Palo Alto CA, US
Jeffrey P. MCMAHON - Mountain View CA, US
Jay POWERS - Pacifica CA, US
Yibin ZENG - Foster City CA, US
Penglie ZHANG - Foster City CA, US
Junfa FAN - , US
Assignee:
ChemoCentryx, Inc. - Mountain View CA
International Classification:
A61K 31/551
C07D 417/06
C07D 417/14
A61P 29/00
A61P 35/00
A61P 17/02
C12N 5/02
US Classification:
51421018, 540575, 514218, 435375
Abstract:
Compounds having formula I,or pharmaceutically acceptable salts, hydrates or N-oxides thereof are provided and are useful for binding to CXCR7, and treating diseases that are dependent, at least in part, on CXCR7 activity. Accordingly, the present invention provides in further aspects, compositions containing one or more of the above-noted compounds in admixture with a pharmaceutically acceptable excipient.

Modulators Of Cxcr7

US Patent:
2011001, Jan 20, 2011
Filed:
Mar 29, 2010
Appl. No.:
12/749434
Inventors:
Xi Chen - Palo Alto CA, US
Pingchen Fan - Fremont CA, US
Mark M. Gleason - Redwood City CA, US
Juan C. Jaen - Burlingame CA, US
Lianfa Li - Palo Alto CA, US
Jeffrey P. McMahon - Mountain View CA, US
Jay Powers - Pacifica CA, US
Yibin Zeng - Foster City CA, US
Penglie Zhang - Foster City CA, US
Assignee:
ChemoCentryx, Inc. - Mountain View CA
International Classification:
A61K 51/00
C07D 417/06
C07D 417/14
C07D 401/14
C07D 413/14
A61K 31/551
A61K 49/00
A61P 35/00
A61P 29/00
A61P 25/00
A61P 43/00
C12N 5/071
US Classification:
424 165, 540575, 51421018, 514218, 424 91, 435375
Abstract:
Compounds having formula I,or pharmaceutically acceptable salts, hydrates or N-oxides thereof are provided and are useful for binding to CXCR7, and treating diseases that are dependent, at least in part, on CXCR7 activity. Accordingly, the present invention provides in further aspects, compositions containing one or more of the above-noted compounds in admixture with a pharmaceutically acceptable excipient.

Aza-Aryl 1H-Pyrazol-1-Yl Benzene Sulfonamides

US Patent:
2013022, Aug 29, 2013
Filed:
Feb 28, 2013
Appl. No.:
13/781412
Inventors:
Junfa FAN - Foster City CA, US
Pingchen FAN - Fremont CA, US
Antoni KRASINSKI - San Jose CA, US
Lianfa LI - San Jose CA, US
Rebecca M. LUI - Santa Clara CA, US
Jeffrey P. McMAHON - San Francisco CA, US
Jay P. POWERS - Pacifica CA, US
Yibin ZENG - Foster City CA, US
Penglie ZHANG - Foster City CA, US
Assignee:
CHEMOCENTRYX, INC. - Mountain View CA
International Classification:
C07D 405/14
A61K 31/4709
A61K 45/06
C07D 403/10
A61K 31/4725
C07D 231/42
A61K 31/415
A61K 31/502
A61K 31/5377
C07D 401/04
C07D 401/10
A61K 31/517
US Classification:
5142352, 546167, 514314, 435375, 544284, 51426623, 5483721, 514407, 544237, 514248, 544128, 546162, 514313, 546143, 514310
Abstract:
Compounds are provided that act as potent antagonists of the CCR(9) receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR(9). The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR(9)-mediated diseases, and as controls in assays for the identification of CCR(9) antagonists.

Coated Abrasive Sheet Material With Loop Material For Attachment Incorporated Therein

US Patent:
5254194, Oct 19, 1993
Filed:
Aug 21, 1991
Appl. No.:
7/748038
Inventors:
Ronald L. Ott - Lake Elmo MN
Michael R. Gorman - White Bear Lake MN
Dennis L. Becker - Vadnais Heights MN
Donald W. Folske - Oakdale MN
William L. Melbye - Minneapolis MN
Susan K. Nestegard - Woodbury MN
David E. Slama - Vadnais Heights MN
John L. Barry - North St. Paul MN
Jeffrey R. McMahon - Woodbury MN
Assignee:
Minnesota Mining and Manufacturing Company - St. Paul MN
International Classification:
B32B 3108
US Classification:
156176
Abstract:
A sheet of coated abrasive material including a backing having abrasive on one surface and loops projecting from its other surface by which the sheet of coated abrasive material can be held by hooks on the support surface of a pad. The backing comprises a polymeric bonding layer defining its rear surface. The sheet of coated abrasive material comprises a nonwoven sheet of longitudinally oriented fibers having anchor portions bonded in the polymeric bonding layer at spaced bonding locations, and arcuate portions projecting from the rear surface of the backing between the bonding locations to provide the loops.

Coated Abrasive Sheet Material With Loop Material For Attachment Incorporated Therein

US Patent:
5354591, Oct 11, 1994
Filed:
Aug 2, 1993
Appl. No.:
8/100770
Inventors:
Ronald L. Ott - Lake Elmo MN
Michael R. Gorman - White Bear Lake MN
Dennis L. Becker - Vadnais Heights MN
Donald W. Folske - Oakdale MN
William L. Melbye - Minneapolis MN
Susan K. Nestegard - Woodbury MN
David F. Slama - Vadnais Heights MN
John L. Barry - North St. Paul MN
Jeffrey R. McMahon - Woodbury MN
Assignee:
Minnesota Mining and Manufacturing Company - St. Paul MN
International Classification:
B32B 306
US Classification:
428 99
Abstract:
A sheet of coated abrasive material including a backing having abrasive on one surface and loops projecting from its other surface by which the sheet of coated abrasive material can be held by hooks on the support surface of a pad. The backing comprises a polymeric bonding layer defining its rear surface. The sheet of coated abrasive material comprises a nonwoven sheet of longitudinally oriented fibers having anchor portions bonded in the polymeric bonding layer at spaced bonding locations, and arcuate portions projecting from the rear surface of the backing between the bonding locations to provide the loops.

Methods Of Treating Generalized Pustular Psoriasis With An Antagonist Of Ccr6 Or Cxcr2

US Patent:
2022028, Sep 8, 2022
Filed:
Nov 16, 2021
Appl. No.:
17/527939
Inventors:
- San Carlos CA, US
Karen EBSWORTH - San Francisco CA, US
Antoni KRASINSKI - Sunnyvale CA, US
Venkat Reddy MALI - Cupertino CA, US
Jeffrey McMAHON - San Francisco CA, US
Rajinder SINGH - Belmont CA, US
Ju YANG - Palo Alto CA, US
Chao YU - Sunnyvale CA, US
Penglie ZHANG - Foster City CA, US
International Classification:
A61K 31/4035
A61P 29/00
A61P 17/06
Abstract:
The present disclosure provides, inter alia, methods of treating generalized pustular psoriasis (GPP) by administering an effective amount of a Chemokine Receptor 6 (CCR6) antagonist and/or a C-X-C motif chemokine receptor 2 (CXCR2) antagonist. Also provided herein are methods of modulating dysregulated IL-36 signaling in a subject in need thereof and methods of reducing neutrophil, inflammatory dendritic cell (iDC), and/or CD4 T cell accumulation in a subject in need thereof, said methods, include dministering an effective amount of a Chemokine Receptor 6 (CCR6) antagonist and/or a C-X-C motif chemokine receptor 2 (CXCR2) antagonist. In some embodiments, the CCR6 and/or CXCR2 antagonist has the formula:

Substituted Anilines As Ccr(4) Antagonists

US Patent:
2022019, Jun 23, 2022
Filed:
Sep 9, 2021
Appl. No.:
17/470464
Inventors:
- San Carlos CA, US
Junfa FAN - Palo Alto CA, US
Christopher W. LANGE - Hayward CA, US
Manmohan Reddy LELETI - Dublin CA, US
Yandong LI - San Diego CA, US
Venkat Reddy MALI - Cupertino CA, US
Jeffrey P. McMAHON - San Francisco CA, US
Jay POWERS - Pacifica CA, US
Sreenivas PUNNA - Sunnyvale CA, US
Ju YANG - Palo Alto CA, US
International Classification:
C07D 413/06
C07D 401/04
C07D 403/06
C07D 405/06
C07D 417/04
C07D 211/56
C07D 295/135
C07D 211/62
C07D 401/06
C07D 211/26
C07D 211/70
C07D 241/04
C07D 207/16
C07D 211/34
A61K 31/451
A61K 31/454
A61K 31/4545
A61K 31/495
A61K 31/496
A61K 31/5377
Abstract:
Aniline compounds are provided which bind to CCR(4) and are useful for the treatment of diseases such as allergic diseases, autoimmune diseases, graft rejection and cancer.

Possible Relatives

Cynthia S Mcmahon  David F Mcmahon  Davida W Mcmahon  Deborah M Mcmahon  Dana M Mcmahon  Debra J Mcmahon  Daniel P Mcmahon  Jeffrey P Johnson  Jeffrey Stamps  Jeffrey Standard 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.